At a glance
ClinicalIndex Comparison RecordN/ACompleted· 20 enrolled
Drug / intervention
Rosuvastatindrug
Likely dose
Rosuvastatin 20 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Effect of Rosuvastatin Response in Healthy Subjects: Potential Mechanisms of
In Brief
An observational study evaluating Rosuvastatin for Healthy. Completed, enrolled 20 participants across 1 site.
Detailed Summary
The purpose of this study is to see whether Statin drugs will act as anti-inflammatories. The investigators will study this potential anti-inflammatory activity in healthy subjects.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
First PostedApr 2009
Enrollment StartNov 2010
Primary CompletionSep 2011
TodayJul 2026
First PostedApr 2, 2009
Enrollment StartNov 15, 2010
Primary CompletionSep 1, 2011
TodayJul 2, 2026
Enrollment to primary: 10 monthsPosted 17.3 years ago
Interventions
Rosuvastatindrug
Healthy subjects received rosuvastatin 20 mg orally for 3 weeks. Inflammatory markers measured pre- and post- rosuvastatin treatment.